Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome

Annette K. Taylor, John F. Safanda, Majilinde Z. Fall, Cindy Quince, Kirsten A. Lang, Claire E. Hull, Isabelle Carpenter, Louise W. Staley, Randi J Hagerman

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Fragile X syndrome is caused by a mutation involving expansion of a CGG trinucleotide repeat segment in the fragile X mental retardation—1 (FMR1) gene on the long arm of the X chromosome. This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation— number of CGG repeats, methylation status, and X inactivation ratio—on the cognitive involvement of female carriers of fragile X syndrome. —Retrospective study with new DNA analysis of known female carriers of fragile X syndrome. —Molecular studies were conducted in a university-based DNA diagnostic laboratory. Patients were originally ascertained through a regional fragile X clinic in a university-affiliated pediatric hospital. —Forty-eight female carriers of fragile X syndrome were studied, including 22 with a premutation (a small expansion to approximately 50 to 200 CGG repeats), 23 with a full mutation (a full expansion to >200 CGG repeats), and three with both types of mutations (mosaics). —Median IQ score was significantly lower for females with a full mutation than for females with a premutation. No significant relationship was found between IQ score and number of CGG repeats or percentage methylation of the mutant allele within each mutation category. In addition, no significant relationship was found between IQ score and the proportion of normal FMR1 alleles on the active X chromosome in the carrier female group as a whole or in either mutation subgroup. Comparisons of leukocytes and saliva-borne epithelial cells in certain full-mutation carriers revealed striking differences in FMR1 mutation sizes. —Mutation category remains the most important predictor of affectedness in female carriers of fragile X syndrome. Our data do not support use of the proportion of normal FMR1 alleles on the active X chromosome as a predictor of cognitive involvement in female carriers with full mutations. Individual tissue-specific differences exist in the heterogeneous sizes of full mutations and in the presence of premutation/full-mutation mosaicism. (JAMA. 1994;271:507-514).

Original languageEnglish (US)
Pages (from-to)507-514
Number of pages8
JournalJAMA - Journal of the American Medical Association
Volume271
Issue number7
DOIs
StatePublished - Feb 16 1994
Externally publishedYes

Fingerprint

Fragile X Syndrome
Mutation
X Chromosome
Alleles
Methylation
Trinucleotide Repeats
X Chromosome Inactivation
Pediatric Hospitals
Mosaicism
DNA
Saliva

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome. / Taylor, Annette K.; Safanda, John F.; Fall, Majilinde Z.; Quince, Cindy; Lang, Kirsten A.; Hull, Claire E.; Carpenter, Isabelle; Staley, Louise W.; Hagerman, Randi J.

In: JAMA - Journal of the American Medical Association, Vol. 271, No. 7, 16.02.1994, p. 507-514.

Research output: Contribution to journalArticle

Taylor, AK, Safanda, JF, Fall, MZ, Quince, C, Lang, KA, Hull, CE, Carpenter, I, Staley, LW & Hagerman, RJ 1994, 'Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome', JAMA - Journal of the American Medical Association, vol. 271, no. 7, pp. 507-514. https://doi.org/10.1001/jama.1994.03510310037035
Taylor, Annette K. ; Safanda, John F. ; Fall, Majilinde Z. ; Quince, Cindy ; Lang, Kirsten A. ; Hull, Claire E. ; Carpenter, Isabelle ; Staley, Louise W. ; Hagerman, Randi J. / Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome. In: JAMA - Journal of the American Medical Association. 1994 ; Vol. 271, No. 7. pp. 507-514.
@article{349cb8a5ffc84e469136d52cfbecddf0,
title = "Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome",
abstract = "Fragile X syndrome is caused by a mutation involving expansion of a CGG trinucleotide repeat segment in the fragile X mental retardation—1 (FMR1) gene on the long arm of the X chromosome. This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation— number of CGG repeats, methylation status, and X inactivation ratio—on the cognitive involvement of female carriers of fragile X syndrome. —Retrospective study with new DNA analysis of known female carriers of fragile X syndrome. —Molecular studies were conducted in a university-based DNA diagnostic laboratory. Patients were originally ascertained through a regional fragile X clinic in a university-affiliated pediatric hospital. —Forty-eight female carriers of fragile X syndrome were studied, including 22 with a premutation (a small expansion to approximately 50 to 200 CGG repeats), 23 with a full mutation (a full expansion to >200 CGG repeats), and three with both types of mutations (mosaics). —Median IQ score was significantly lower for females with a full mutation than for females with a premutation. No significant relationship was found between IQ score and number of CGG repeats or percentage methylation of the mutant allele within each mutation category. In addition, no significant relationship was found between IQ score and the proportion of normal FMR1 alleles on the active X chromosome in the carrier female group as a whole or in either mutation subgroup. Comparisons of leukocytes and saliva-borne epithelial cells in certain full-mutation carriers revealed striking differences in FMR1 mutation sizes. —Mutation category remains the most important predictor of affectedness in female carriers of fragile X syndrome. Our data do not support use of the proportion of normal FMR1 alleles on the active X chromosome as a predictor of cognitive involvement in female carriers with full mutations. Individual tissue-specific differences exist in the heterogeneous sizes of full mutations and in the presence of premutation/full-mutation mosaicism. (JAMA. 1994;271:507-514).",
author = "Taylor, {Annette K.} and Safanda, {John F.} and Fall, {Majilinde Z.} and Cindy Quince and Lang, {Kirsten A.} and Hull, {Claire E.} and Isabelle Carpenter and Staley, {Louise W.} and Hagerman, {Randi J}",
year = "1994",
month = "2",
day = "16",
doi = "10.1001/jama.1994.03510310037035",
language = "English (US)",
volume = "271",
pages = "507--514",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome

AU - Taylor, Annette K.

AU - Safanda, John F.

AU - Fall, Majilinde Z.

AU - Quince, Cindy

AU - Lang, Kirsten A.

AU - Hull, Claire E.

AU - Carpenter, Isabelle

AU - Staley, Louise W.

AU - Hagerman, Randi J

PY - 1994/2/16

Y1 - 1994/2/16

N2 - Fragile X syndrome is caused by a mutation involving expansion of a CGG trinucleotide repeat segment in the fragile X mental retardation—1 (FMR1) gene on the long arm of the X chromosome. This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation— number of CGG repeats, methylation status, and X inactivation ratio—on the cognitive involvement of female carriers of fragile X syndrome. —Retrospective study with new DNA analysis of known female carriers of fragile X syndrome. —Molecular studies were conducted in a university-based DNA diagnostic laboratory. Patients were originally ascertained through a regional fragile X clinic in a university-affiliated pediatric hospital. —Forty-eight female carriers of fragile X syndrome were studied, including 22 with a premutation (a small expansion to approximately 50 to 200 CGG repeats), 23 with a full mutation (a full expansion to >200 CGG repeats), and three with both types of mutations (mosaics). —Median IQ score was significantly lower for females with a full mutation than for females with a premutation. No significant relationship was found between IQ score and number of CGG repeats or percentage methylation of the mutant allele within each mutation category. In addition, no significant relationship was found between IQ score and the proportion of normal FMR1 alleles on the active X chromosome in the carrier female group as a whole or in either mutation subgroup. Comparisons of leukocytes and saliva-borne epithelial cells in certain full-mutation carriers revealed striking differences in FMR1 mutation sizes. —Mutation category remains the most important predictor of affectedness in female carriers of fragile X syndrome. Our data do not support use of the proportion of normal FMR1 alleles on the active X chromosome as a predictor of cognitive involvement in female carriers with full mutations. Individual tissue-specific differences exist in the heterogeneous sizes of full mutations and in the presence of premutation/full-mutation mosaicism. (JAMA. 1994;271:507-514).

AB - Fragile X syndrome is caused by a mutation involving expansion of a CGG trinucleotide repeat segment in the fragile X mental retardation—1 (FMR1) gene on the long arm of the X chromosome. This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation— number of CGG repeats, methylation status, and X inactivation ratio—on the cognitive involvement of female carriers of fragile X syndrome. —Retrospective study with new DNA analysis of known female carriers of fragile X syndrome. —Molecular studies were conducted in a university-based DNA diagnostic laboratory. Patients were originally ascertained through a regional fragile X clinic in a university-affiliated pediatric hospital. —Forty-eight female carriers of fragile X syndrome were studied, including 22 with a premutation (a small expansion to approximately 50 to 200 CGG repeats), 23 with a full mutation (a full expansion to >200 CGG repeats), and three with both types of mutations (mosaics). —Median IQ score was significantly lower for females with a full mutation than for females with a premutation. No significant relationship was found between IQ score and number of CGG repeats or percentage methylation of the mutant allele within each mutation category. In addition, no significant relationship was found between IQ score and the proportion of normal FMR1 alleles on the active X chromosome in the carrier female group as a whole or in either mutation subgroup. Comparisons of leukocytes and saliva-borne epithelial cells in certain full-mutation carriers revealed striking differences in FMR1 mutation sizes. —Mutation category remains the most important predictor of affectedness in female carriers of fragile X syndrome. Our data do not support use of the proportion of normal FMR1 alleles on the active X chromosome as a predictor of cognitive involvement in female carriers with full mutations. Individual tissue-specific differences exist in the heterogeneous sizes of full mutations and in the presence of premutation/full-mutation mosaicism. (JAMA. 1994;271:507-514).

UR - http://www.scopus.com/inward/record.url?scp=84942951309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942951309&partnerID=8YFLogxK

U2 - 10.1001/jama.1994.03510310037035

DO - 10.1001/jama.1994.03510310037035

M3 - Article

VL - 271

SP - 507

EP - 514

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 7

ER -